Alta Life Sciences

Alta Life Sciences is a leading multistage venture capital firm investing in companies at all stages of development, from seed financing through commercial growth. The firm focuses on breakthrough scientific discoveries that address unmet medical needs, with a high societal impact and potential for significant returns. Their investment areas include biotechnology, medical devices, diagnostics, genomics, and digital health.

Headquartered in Barcelona, Spain, Alta Life Sciences serves as a bridge fund connecting the Spanish and European life sciences ecosystem with the venture capital expertise of Silicon Valley. The management team, led by Guy P. Nohra, includes experienced professionals from the U.S. and Spain with complementary backgrounds and skills. Nohra is a co-founder of Alta Partners, a leading venture capital firm in life sciences, and was named to the 2007 Forbes Midas List of dealmakers in Venture Capital.

In October 2025, Alta Life Sciences integrated its life sciences investment platform, Aliath Bioventures, with Asabys Partners, a Spanish venture capital firm specialized in healthcare, and AltamarCAM Partners, a global investment firm. This strategic move aims to build a life sciences investment platform in Europe with assets under management exceeding €1 billion by 2030. The combined team plans to launch new life sciences funds across diverse market segments and deepen collaboration to strengthen their position in the European market.

Investment Requirements: Alta Life Sciences seeks to invest in companies with breakthrough scientific discoveries that address unmet medical needs, aiming for both high societal impact and potential returns. They focus on sectors such as biotechnology, medical devices, diagnostics, genomics, and digital health, and are open to investments outside Spain, leveraging their expertise to connect the Spanish and European ecosystems with global venture capital opportunities.